DiaSorin S.p.A
Save
5.47B
Market cap
28.91x
Current P/E
22.42x
Forward P/E
About
Health care
Sector
Medical - Diagnostics & Research
Industry
DiaSorin S.p. A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIAISON XL, and LIAISON XL LAS; and molecular diagnostics platform comprising of LIAISON MDX for use in the amplification of nucleic acids to diagnose viral infections through the identification of virus in patient's biological sample.
Similar securities
Based on sector and market capitalization
Report issue